Medworld医疗世界为您提供准确、及时、有用的医疗器械行业及医疗圈的市场动态，产品信息，技术进展等
资讯
！
来源：Business by MDDI
Verily Life Sciences has formed yet another joint venture with a medtech company. This time Verily, once known as Google’s life sciences division, is teaming up with sleep-health specialist ResMed to tackle sleep apnea. The collaboration with ResMed expands the Mountain View, CA-based company’s presence into yet another healthcare segment.
ResMed executives declined to discuss specific details about the joint venture, noting it was still subject to regulatory approvals. However, ResMed CMO Carlos Nunez said the joint venture will operate as a completely separate entity from ResMed and Verily.
Nunez noted ResMed had extensive data on sleep apnea patients and the largest platform of connected medical devices in the home than any other firm, which makes it the perfect partner for Verily Life Sciences.
Under the joint venture, Verily and San Diego, CA-based ResMed will study the health and financial impacts of undiagnosed and untreated sleep apnea and develop software solutions that enable healthcare providers to more efficiently identify, diagnose, treat, and manage individuals with sleep apnea and other breathing related sleep disorders.
“[ResMed] has the expertise, the knowledge, and extensive data sets in sleep apnea; and Verily has the expertise in advanced analytics and a track record for partnering with companies in the medtech space, Nunez, told
MD+DI
. “We think the joint venture will help us do a more compelling job in understanding what sleep apnea is and how better to engage with patients.”
The companies said that sleep apnea impacts more than 54 million people in the U.S. and is associated with heart, stroke, type 2 diabetes, and other disease conditions.
